Protemix founder named NZ's 'biotechnologist of the year'
Tuesday, 15 March, 2005
Prof Garth Cooper, the president and chief scientist of Auckland-based Protemix, has been named NZBio's 'distinguished biotechnologist of the year' at the New Zealand biotech organisation's conference.
Cooper founded Protemix in 1999, when he had returned to Auckland after a spectacular career in the UK and US. While a Nuffield fellow at Oxford, he discovered the hormone amylin, and developed it into a new therapy for diabetes mellitus. He patented his discoveries and in 1987 founded biopharma company Amylin, which later listed on Nasdaq. Amylin's market capitalisation is now around US$2 billion.
He has stated that his aim in founding Protemix was to create New Zealand's first billion-dollar biotech company.
Accepting his award yesterday evening, Cooper issued a plea to funding bodies not to write off innovative science as mere "fishing expeditions", and put innovation at risk.
Widespread resistance to common antibiotics is increasing: WHO
Increasing resistance to essential antibiotics poses a growing threat to global health, with one...
Dopamine helps our brains to let go of memories
In a discovery that could reshape how we think about memory, researchers at Flinders University...
Vaccine for elephant herpesvirus found to be safe
The vaccine could prevent deadly elephant endotheliotropic herpesvirus in calves — the...
